Melbourne Health

Global study could change how children with multiple sclerosis are treated

A global study has found that children with multiple sclerosis who are treated early and with the same high-efficacy therapies as adults have better outcomes. The study, which analyzed data from over 5,000 people diagnosed with MS during childhood, suggests that these therapies can help preserve neurological capacity before it's damaged.

SourceMelbourne Health·JournalThe Lancet Child & Adolescent Health·TypeObservational study·DateMar 25, 2024

New study 'game-changer' for stroke treatment worldwide

A landmark study published in the New England Journal of Medicine shows a dramatic improvement in restoring blood flow to the brain after adding stent thrombectomy to standard clot-dissolving therapy. The new treatment restores blood flow to 89% of patients, with 71% returning to independent living.

SourceMelbourne Health·JournalNew England Journal of Medicine·DateFeb 11, 2015

Epilepsy drug dosage linked to specific birth defects

A new study has found a link between high doses of epilepsy medication valproate and increased risk of physical birth defects such as spina bifida and hypospadias in babies. Reducing the dose of valproate during pregnancy can significantly lower this risk, providing pregnant women with epilepsy new hope.

SourceMelbourne Health·JournalNeurology·DateAug 25, 2013